Skip to main content

Table 2 Disease-free and overall survival by AJCC stage (7th edition) for non-metastatic patients with thick melanoma (≥ 4 mm)

From: Thick primary melanoma has a heterogeneous tumor biology: an institutional series

AJCC STAGE

DISEASE-FREE SURVIVAL

OVERALL SURVIVAL

 

5 year

10 year

5 year

10 year

IIB

56.9%

42.3%

58.2%

43.1%

IIC

42.8%

0%

45.5%

12.1%

IIIA

40.8%

18.2%

54.6%

20.3%

IIIB

30.3%

30.3%

33.0%

33.0%

IIIC

10.0%

0%

13.1%

0%

p value

0.0001

 

0.0004